Using body composition and kidney function measurements to assess nutrition in hemodialysis patients
Official title: Integrating Bioelectrical Impedance Analysis and Estimated Glomerular Filtration Rate: A Novel Approach to Assessment of Nutritional Status of Hemodialysis Patients
Run by University of Tartu · NCT06873880 · Data updated 2026-11-12
This study is testing if using body composition and kidney function measurements can help better understand the nutrition of people on hemodialysis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Tartu Academic / other |
| Locations | 1 site (Tartu, Tartu) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | May 31, 2025 |
| Study ends | July 30, 2025 |
| Registry record updated | March 13, 2025 |
| Trial ID | NCT06873880 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with chronic kidney disease who have been on hemodialysis for at least six months.
✕Probably not a fit
Patients who are pregnant, lactating, have a major second pathology, have a pacemaker, or have undergone recent surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the combined use of Bioelectrical Impedance Analysis (BIA) and estimated glomerular filtration rate (eGFR) to evaluate the nutritional status of patients undergoing hemodialysis. By correlating body composition metrics obtained from BIA with kidney function estimates from eGFR, the study aims to provide a more accurate, non-invasive assessment of health in these patients. The research focuses on addressing malnutrition and fluid imbalances, which are prevalent in this population, by improving current assessment methods that rely on basic tests and observations.
Why it matters
Potential benefit: If successful, this approach could lead to improved nutritional monitoring and better treatment decisions for hemodialysis patients.
How similar studies have gone: While the integration of BIA and eGFR is a novel approach, similar studies have shown promise in improving nutritional assessments in other patient populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Chronic kidney disease Hemodialysis for at least 6 months Exclusion Criteria: Pregnancy Lactation Major second pathology Pacemaker Recent surgery
Where it's running
-
Institute of Clinical Medicine
Tartu, Tartu, Estonia Recruiting
Study contacts
- Study coordinator: Anum Basit Masters student, BSc
- Email: anumbasit.08@gmail.com
- Phone: +372 5367 2243
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pumpkin seed oil for people on hemodialysis
This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.
-
How dialysis affects sexual function and intimacy
This project will see how dialysis affects sexual health and intimacy in adults who have been on hemodialysis or peritoneal dialysis for at least six months.
-
AP306 at fixed doses in adults on dialysis with high phosphate
This trial tests if AP306, taken daily at different doses, can safely lower phosphate levels in adults on maintenance dialysis with hyperphosphatemia.
-
Dialysis that removes more middle molecules using super high‑flux filters
This trial will test whether using super high‑flux (expanded) dialysis filters instead of standard high‑flux filters reduces the risk of death and other harms for adults on in‑center hemodialysis who are older or have diabetes.
-
How kidney failure changes antibody responses to influenza and COVID vaccines
This project will see if adults on chronic dialysis make as much protective antibody after influenza or SARS‑CoV‑2 vaccination as people without kidney disease.
-
Evaluating the BETY-BQ Questionnaire for Chronic Kidney Disease and Transplant Patients
This study is testing a new questionnaire to see how well it helps understand the challenges faced by people with chronic kidney disease, those on dialysis, and kidney transplant patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.